Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
World Journal of Gastroenterology|October 16, 2012
Effectiveness of infliximab after adalimumab failure in Crohn's diseaseMaría Chaparro, Montserrat Andreu, Manuel Barreiro-de Acosta, et al.
Gastroenterologia Y Hepatologia|October 14, 2019
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosisManuel Barreiro-de Acosta, Ana Gutierrez, Iago Rodríguez-Lago, et al.
Gastroenterologia Y Hepatologia|January 22, 2022
The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's diseasePablo Ladrón Abia, Noelia Alonso, Alejandro Mínguez Sabater, et al.
Digestive Diseases (Basel, Switzerland)|August 28, 2018
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's DiseaseBelén Beltrán, Marisa Iborra, Esteban Sáez-González, et al.
Gastroenterologia Y Hepatologia|July 23, 2018
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agentsMarisa Iborra, Belén Beltrán, Nuria Maroto, et al.
Gastroenterologia Y Hepatologia|July 1, 2020
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: TreatmentManuel Barreiro-de Acosta, Ignacio Marín-Jimenez, Iago Rodríguez-Lago, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 5, 2019
Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control studyEduard Cabré, Míriam Mañosa, Ignacio Marín, et al.
Inflammatory Bowel Diseases|July 15, 2017
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical PracticeMariam Aguas Peris, Virginia Bosó, Belén Navarro, et al.
International Journal of Molecular Sciences|February 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic ReviewOctavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria, et al.
Gastroenterologia Y Hepatologia|September 13, 2024
Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and adjusted regimen in real worldAlejandro Mínguez, Elena Coello, Alejandro Garrido, et al.
Pageof 15